We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow %
97%
Top 10 Hldgs %
17.3%
Holding
278
New
278
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$3.89M
2
T icon
AT&T
T
+$3.66M
3
CVS icon
CVS Health
CVS
+$3.54M
4
ACN icon
Accenture
ACN
+$3.24M
5
CRM icon
Salesforce
CRM
+$3.04M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Healthcare 17.6%
3 Industrials 10.85%
4 Consumer Discretionary 10.48%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMBA icon
276
Ambarella
AMBA
$3.64B
$1K ﹤0.01%
+15
New +$1.1K
MRCY icon
277
Mercury Systems
MRCY
$6.46B
$0 ﹤0.01%
+6
New +$256
PPC icon
278
Pilgrim's Pride
PPC
$6.32B
$0 ﹤0.01%
+12
New +$270
8 9 10 11
12

Similar funds

MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
ACA
Anchorage Capital Advisors New York $378M AUM 13.47% 1-Year Est. Return
AFCM
Alta Fox Capital Management Fort Worth, Texas $378M AUM 59.19% 1-Year Est. Return
DAL
Delta Air Lines Atlanta, Georgia $378M AUM 12.68% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
FP
Fivespan Partners San Francisco, California $377M AUM
C
Cliffwater Marina Del Rey, California $377M AUM 5.73% 1-Year Est. Return
HCP
Hiddenite Capital Partners New York $381M AUM 73.07% 1-Year Est. Return

Neo Ivy Capital Management's Q2 2023 Portfolio in Review

Q2 2023 is the first quarter with a 13F filing on record for Neo Ivy Capital Management, which disclosed 278 positions worth $190M. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Humana: 7,737 shares worth $3.46M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Industrials.

  • Neo Ivy Capital Management's largest Q2 2023 buy was Humana: 7,737 shares worth $3.46M.
  • Neo Ivy Capital Management's ten largest holdings make up 17% of its $190M portfolio in Q2 2023.
  • Neo Ivy Capital Management disclosed 278 positions in Q2 2023, its first 13F filing on record.

Based on Neo Ivy Capital Management's 13F filing for Q2 2023, filed 16 Aug 2023.